Client’s Testimonial:
On March 11th, 2020, we received another NIW (National Interest Waiver) approval for a Researcher in the Field of Pharmaceutics (Approval Notice).
General Field: Pharmaceutics
Position at the Time of Case Filing: Researcher
Country of Origin: China
State of Residence at the Time of Filing: North Carolina
Approval Notice Date: March 11th, 2020
Processing Time: 8 months
Case Summary:
Our client for this EB-2 NIW (National Interest Waiver) petition is a researcher who is conducting his important research in the ever-expanding field of pharmaceutics. With a Ph.D. degree in Pharmaceutics, our client’s research on developing novel nanoparticle-based drug delivery systems that enhance cancer treatments has centered on understanding the mechanisms of drug delivery and thereby enhancing drug efficacy, particularly in terms of cancer therapeutics. Because this contributes to such a massive international industry, his research is clearly of global economic importance. Our goal was to highlight our client’s strengths and skills and convince the USCIS that he deserved the national interest waiver. We approached his case with the utmost thoroughness and made sure every necessary evidence regarding the significance of our client’s extensive research was presented.
The most notable accomplishment of our client is that he has offered the field a number of innovative research projects, which he has expounded upon in his publications. His successful research resulted in 9 peer-reviewed journal articles (4 of them first-authored), one book chapter, and 214 citations at the time of application submission. We also noted the 40 times our client judged the work of his peers. Below words from a noted expert can confirm that our client is widely recognized and relied upon in his field of expertise, “[Client] has carried out important research to make this approach even stronger by improving the performance of the IP drug delivery system in an innovative way. His work in this area has already had a massive impact on how we handle and design IP chemotherapy, demonstrating that he is an influential figure in this line of research.”
As our client has produced significant research on this subject, it is reasonable to conclude that his future research will yield equally valuable results. North America Immigration Law Group (NAILG) diligently customized his petition with all the meticulous details that were required for a substantial case. Our success with over 16,000 approved I-140 cases has given our team the experience and skill to work with similar cases with a high rate of success and thus resulted in our client’s NIW approval.
We really appreciate our client for trusting us with the preparation of his case and for giving us an opportunity to be a part of his success story. We wish him all the best for his future endeavors as he takes his research further in the United States.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.
![](https://www.wegreened.com/blog/wp-content/uploads/2020/03/approval_table_2020.jpg)
If you are interested in filing the green card, please send your CV to law@wegreened.com for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.
Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://www.wegreened.com/blog/
Website: www.wegreened.com
Free evaluation email: law@wegreened.com
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.